NEW YORK – French rapid test maker Biosynex said late Tuesday that it has reached a definitive agreement to acquire Chembio Diagnostics for $17.2 million in cash. Under the deal, Biosynex

Despite its overall revenue growth, Thermo Fisher saw virtually no change—in either direction—for its organic revenues, which exclude the impacts of the company’s acquisitions and of changes in foreign exchange

NEW YORK – Sherlock Biosciences announced on Wednesday that it will acquire Cambridge, UK, molecular diagnostics company Sense Biodetection for undisclosed terms. The firms intend to pair Sherlock’s CRISPR, synthetic

Goldfinch Bio’s swift curtain call comes less than three years after the company raised a $100 million series B.  Goldfinch Bio, a 2020 Fierce Biotech Fierce 15 winner, is shutting

Celgene spinout Celularity has left an ax dangling over a “substantial portion” of its workforce. While the cell therapy firm is “hopeful” it can avoid significant layoffs, it has told many staffers

NEW YORK – Guardant Health has laid off approximately 7 percent of its workforce, the company confirmed on Wednesday, or about 130 individuals. According to terminated employees posting on LinkedIn,

AstraZeneca initially pitched an offer of $54 per share, double what the Big Pharma would ultimately pay for CinCor. AstraZeneca kicked off this year’s J.P.Morgan Healthcare Conference in style, announcing

An onsite manufacturing facility will allow the company to maintain full oversight of its production. Eitan Medical, a manufacturing company focused on advanced infusion therapy and drug delivery solutions, recently announced the

The most recent addition to Caris’ offerings is the Assure molecular profiling assay, which sequences the entire genome to look for mutations that may be linked to cancer. After blowing

PAVmed and its subsidiaries, Lucid and Veris, will also implement a strategic plan that will hopefully lower quarterly cash-burn by 25%. PAVmed, a commercial-stage medical technology company, and its majority-owned

Gilead’s new research building is designed to include about 175,000 square feet of digitally enabled lab space. Gilead Sciences is expanding with a new research center that’s plotted in headquarters

NEW YORK – PAVmed and its subsidiaries Lucid Diagnostics and Veris Health announced on Tuesday that they have laid off 20 percent of their employees in an effort to lower

AcuFocus has developed the IC-8 Apthera intraocular lens (IOL), which was approved by FDA in July 2022. The deal volume in 2023 is already off to a strong start in

The San Diego, CA-based company is facing a fine because of closing the Grail acquisition without waiting for EU antitrust approval, according to a Reuters report. The fallout from Illumina’s

“We will center our strategy on closing the gap between research and care, and becoming the data and evidence backbone for precision health, with a focus on applying AI and